N/A N=70 Hysterectomy by Transabdominal Laparoscopy or NOTES
Uterine Diseases
Primary: Successful Removal of the Uterus Without Conversion to Another Technique — 35; 35 Participants — p=0.0221
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=167 A Comparison of Narrow Band Imaging (NBI) and Standard White Light Laparoscopy to Detect Endometriosis
Endometriosis
Primary: Diagnostic Yield — 81; 25 participants
Phase 2 N=50 Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies
Fallopian Tube Cancer · Ovarian Sarcoma · Ovarian Stromal Cancer
Primary: Acute Toxicity Rate — 6 percentage of participants
N/A N=1,105 Female Patient Preferences Regarding Physician Gender
Female Patient Preference
Primary: Proportion of Female Respondents Having Their Preferences Based on Physician Gender for the OB/GYN Care — 667; 87; 261 Participants
Early Phase 1 N=103 Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study
Cervical Cancer · Uterine Endometrial Cancer · Ovarian Cancer
Primary: Hospital Stay — 3.0; 3.0 Days — p=0.36
N/A N=30 Estrogen Sensitivity and Ovulatory Dysfunction in Obesity
Obesity · Infertility
Primary: Luteinizing Hormone Pulse Amplitude — 2.73; 1.12 IU/L
N/A N=351 Point of Care Diagnosis of Vaginal Infections
Vaginitis · Bacterial Vaginosis · Yeast Vaginitis
Primary: Number of Participants Prescribed Appropriate Treatment — 61; 104; 58; 21 Participants — p=<.001
Early Phase 1 N=6 Investigation of Female Reproductive Hormone Dynamics During Adolescence
Menstruation Disturbances
Primary: Ovulation in Cycle 2 — 3; 2 Participants
N/A N=491 Evaluation of Postoperative Blood Pressure Changes After Benign Gynecologic Surgery
Urogynecology
Primary: Percentage of Participants Who Underwent Gynecologic Surgery — 42; 32; 26 percentage of participants
N/A N=66 Impact of Decision Aids in Urogynecology
Pelvic Organ Prolapse · Stress Urinary Incontinence · Overactive Bladder
Primary: Patient Knowledge — 60; 72 percentage of questions answered correct — p=0.06
N/A N=110 Acupuncture for Post-Operative Pain Control for Patients Undergoing Gynecological Surgery
Post-operative Pain · Gynecological Surgery · Acupuncture
Primary: Morphine Equivalent Usage While in the Hospital — 29.59; 30.82; 10.54; 11.74 mg
Phase 2 N=21 Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers
Cervical Cancer · Endometrial Cancer · Ovarian Cancer
Primary: Toxicity Rates of Patients Treated With Concurrent Avastin and Daily Pelvic Radiation With no Other Concurrent Chemotherapy — 766 Events
N/A N=328 Diagnostic Accuracy of "Three Rings Vulvoscopy" for Detection of Vulvar Dermatosis
Lichen Sclerosus · Lichen Planus · Lichen Simplex Chronicus
Primary: Diagnostic Accuracy of "Three Rings Vulvoscopy" by the "Vulvoscopy Index" for Detection of Vulvar Dermatosis — 72; 0; 10; 246 Participants — p=0.6108
Early Phase 1 N=9 Gynecological Sentinel Lymph Nodes CEUS
Cervical Carcinoma · Malignant Female Reproductive System Neoplasm · Vaginal Carcinoma
Primary: Number of Sentinel Lymph Nodes (SLNs) Identified by Lymphosonography as Well as Blue Dye or Positron Emission Tomography (PET)-Computed Tomography (CT) — 17 sentinel…
N/A N=80 Gynecologic Brachytherapy-Specific Educational Video
Cervical Cancer · Uterine Cancer
Primary: Patient Reported Satisfaction — 54; 55 satisfaction score at baseline
Phase 2 N=120 Ambulatory Gynecologic Surgery: Finding the Optimal Opioid Prescription
Surgery
Primary: Number of Oxycodone Tablets Used Day 1 — 1.0; 1.0 Oxycodone Tablets — p=.87
N/A N=1,585 Clinical Study of a Diagnostic Device for NG, TV and CT in Women
Chlamydial Infection · Gonococcal Infection · Trichomoniasis
Primary: The i) Percent Sensitivity and ii) Percent Specificity of Click Device for Detection of Chlamydia Trachomatis (CT) in Self-collected Vaginal Specimens as Compared to PIS…
Phase 2 N=93 Image-Guided Gynecologic Brachytherapy
Cervical Cancer · Uterine Cancer · Vaginal Cancer
Primary: Mean Doses Given — 93.9; 63.2; 58.63 Gy
N/A N=250 Anxiety and Distress Levels in Women With Suspected Endometrial Cancer
Endometrial Cancer · Cancer · Uterine Cancer
Primary: Anxiety Score for Patients Attending Clinic — 6 score on a scale
N/A N=15 [18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers
Gynecologic Cancer
Primary: Patients With Changes in Bone Marrow Assessed Through Images — 0; 4 Participants
N/A N=53 Utilizing Telemedicine for Delivery of Postoperative Care
Laparoscopic Gynecologic Surgery
Primary: PSQ-18 General Satisfaction — 4.0; 4.5 score on a scale
Phase 4 N=163 Suppressive Therapy With Oral Antibiotics for Prevention of Postoperative Urinary Tract Infection (UTI)
Urinary Tract Infection
Primary: Urinary Tract Infections — 18; 10 participants
Phase 3 N=301 PGL4001 Versus GnRH-agonist in Uterine Myomas
Uterine Myomas
Primary: Percentage of Subjects With Reduction of Uterine Bleeding at Week 13 Visit Defined as Pictorial Blood-loss Assessment Chart (PBAC) Score < 75 at End-of-treatment Visit…
N/A N=290 To Study Polycystic Ovary Syndrome in Taiwanese Women
Polycystic Ovary Syndrome · Metabolic Syndrome · Cardiovascular Disease
Primary: Total Testosterone — 1.5; 2.9 nmol/L — p=<0.05
N/A N=23 PREvention of Intrauterine Adhesion After Hysteroscopic Surgery With Novel deGradable Film
Intrauterine Adhesion
Primary: Safety (Adverse Events) — 0 device related adverse event
Phase 2 N=44 Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Cervical Cancer · Endometrial Cancer · Fallopian Tube Cancer
Primary: Number of Patients With Venous Thromboembolism at Week 4 — 0 Participants
N/A N=50 Clinical Investigation To Evaluate Cerviron Ovules® in Symptomatic Vaginitis
Vaginitis and Vulvovaginitis
Primary: Number of Participants With the Same Gynaecological Conditions at the End of Treatment Visit — 13 Participants
N/A N=104 Quality of Life in Premenopausal Women With Heavy Menstrual Bleeding
Heavy Menstrual Bleeding
Primary: Hot Flush Frequency Total Score (HFRS) Change — 9.3; 8.8; 12.7 score on a scale
Phase 2 N=30 Papillary Serous Carcinoma of the Endometrium
Endometrial Cancer
Primary: Overall Survival at 2 Years and 5 Years — 93; 85 percentage of participants
Phase 1 N=23 Laparoscopic Narrow Band Imaging for Detection of Occult Cancer Metastases
Gastrointestinal and Gynecologic Malignancies
Primary: Rate of Detectable Peritoneal Metastases — 0; 2 percentage of lesions